AB

Bibliografia publikacji pracowników
Państwowej Szkoły Wyższej w Białej Podlaskiej

Baza tworzona przez Bibliotekę Akademii Bialskiej im. Jana Pawła II.


Zapytanie: KOWALCZYK MARIUSZ
Liczba odnalezionych rekordów: 1



Przejście do opcji zmiany formatu | Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie
1/1
Autorzy: , .
Tytuł czasopisma:
Oznaczenie wydania: 2353-6942003Quality of life of patients with type 2 diabetes in relation to method of treatmentHealth Problems of Civilization20152353-69422015/201610.5114/hpc.2015.57698Daniluk, Jadwigacukrzyca typu 2type 2 diabetesFINAL_PUBLISHEDInappropriate glycaemic control in type 2 diabetes leads to long-term complication and affects length of life. lntensification of treatment, involving insulin therapy is often delayed because of fear of negative influence on quality of life [QoL]. Aims: evaluation of differences on QoL with type 2 diabetes patients in relation to method of current anti- diabetic treatment, especially patients who are on the threshold of insulin therapy introduction. Methods: study involved 274 patients [mean 62.2years, 55.8%F) who were divided into 3 groups: patients treated with oral anti-diabetic agents (OAD group, n=111), patient
Charakterystyka wg MNiSW:
Punktacja ministerstwa: f treatment00000317520000002847AOartykuł oryginalny naukowyPUBLIKACJAPEŁNA PUBLIKACJAABartykuł w czasopiśmie bez IF (wykaz MNiSW)AFILIACJA PODANAENGhttp://www.termedia.pl/QUALITY-OF-LIFE-OF-PATIENTS-WITH-TYPE-Z-DIABETES-IN-RELATION-TO-METHOD-OF-TREATMENT,99,26886,0,0.htmlPRACA RECENZOWANA100^a2353-6942^bB^e2354-0265^fB^gABC^hABC^iX^jXY^a003^b003^c2016-03-08, 10:45^d2016-06-23, 08:26^e3827969194^f3824819413^aQuality of life of patients with type 2 diabetes in relation to method of treatment^aHealth Problems of Civilization^a2015^bVol. 9^cno 4^dp. 26--31^a2353-6942^b2354-0265^a2015/2016^a10.5114/hpc.2015.57698^aDaniluk, Jadwiga^acukrzyca typu 2^atype 2 diabetes^aFINAL_PUBLISHED^bCC-BY-NC^cBEFORE_PUBLICATION^eOPEN_JOURNAL^aInappropriate glycaemic control in type 2 diabetes leads to long-term complication and affects length of life. lntensification of treatment, involving insulin therapy is often delayed because of fear of negative influence on quality of life [QoL]. Aims: evaluation of differences on QoL with type 2 diabetes patients in relation to method of current anti- diabetic treatment, especially patients who are on the threshold of insulin therapy introduction. Methods: study involved 274 patients [mean 62.2years, 55.8%F) who were divided into 3 groups: patients treated with oral anti-diabetic agents (OAD group, n=111), patients, for whom insulin was introduced (lntensification group, n=68) and patients treated with insulin [Insulin group, n=95). QoL was measured with questionnaires: EQ-5D, DQL-BCI and DSC-R. Results: There were no statistically significant differences in EQ-5D indices among studied patients [OAD group-0.82, lntensification group-0.78, Insulin group-O.75]. EQ-VAS among patients switched to insulin therapy was lower than in OAD group (52.7 and 59.3, respectively, p=0.004]. The differences in DQL-BCI scores among all groups of patients were statistically insignificant (scores: OAD group-56.7, lntensification group-54.8, Insulin group-51.7). DSC-R score in lntensification group was higher than among OAD group (30.9 and 25.3, respectively, p=0,08). Patients switched to insulin therapy manifested the highest level of hyperglycemia-related burden and the lowest treatment satisfaction. Conclusions: patients whose treatment was intensified reported their QoL as lower than the patients treated with OAD, however there was no significant difference found in respect of QoL between patients from the latter group and patients already treated with insulin.^ajakość życia^aquality of life^ainsulinoterapia^ainsulin therapy
Słowa kluczowe ang.: to method of treatment00000317520000002847AOartykuł oryginalny naukowyPUBLIKACJAPEŁNA PUBLIKACJAABartykuł w czasopiśmie bez IF (wykaz MNiSW)AFILIACJA PODANAENGhttp://www.termedia.pl/QUALITY-OF-LIFE-OF-PATIENTS-WITH-TYPE-Z-DIABETES-IN-RELATION-TO-METHOD-OF-TREATMENT,99,26886,0,0.htmlPRACA RECENZOWANA100^a2353-6942^bB^e2354-0265^fB^gABC^hABC^iX^jXY^a003^b003^c2016-03-08, 10:45^d2016-06-23, 08:26^e3827969194^f3824819413^aQuality of life of patients with type 2 diabetes in relation to method of treatment^aHealth Problems of Civilization^a2015^bVol. 9^cno 4^dp. 26--31^a2353-6942^b2354-0265^a2015/2016^a10.5114/hpc.2015.57698^aDaniluk, Jadwiga^acukrzyca typu 2^atype 2 diabetes^aFINAL_PUBLISHED^bCC-BY-NC^cBEFORE_PUBLICATION^eOPEN_JOURNAL^aInappropriate glycaemic control in type 2 diabetes leads to long-term complication and affects length of life. lntensification of treatment, involving insulin therapy is often delayed because of fear of negative influence on quality of life [QoL]. Aims: evaluation of differences on QoL with type 2 diabetes patients in relation to method of current anti- diabetic treatment, especially patients who are on the threshold of insulin therapy introduction. Methods: study involved 274 patients [mean 62.2years, 55.8%F) who were divided into 3 groups: patients treated with oral anti-diabetic agents (OAD group, n=111), patients, for whom insulin was introduced (lntensification group, n=68) and patients treated with insulin [Insulin group, n=95). QoL was measured with questionnaires: EQ-5D, DQL-BCI and DSC-R. Results: There were no statistically significant differences in EQ-5D indices among studied patients [OAD group-0.82, lntensification group-0.78, Insulin group-O.75]. EQ-VAS among patients switched to insulin therapy was lower than in OAD group (52.7 and 59.3, respectively, p=0.004]. The differences in DQL-BCI scores among all groups of patients were statistically insignificant (scores: OAD group-56.7, lntensification group-54.8, Insulin group-51.7). DSC-R score in lntensification group was higher than among OAD group (30.9 and 25.3, respectively, p=0,08). Patients switched to insulin therapy manifested the highest level of hyperglycemia-related burden and the lowest treatment satisfaction. Conclusions: patients whose treatment was intensified reported their QoL as lower than the patients treated with OAD, however there was no significant differen ; lving insulin therapy is often delayed because of fear of negative influence on quality of life [QoL]. Aims: evaluation of differences on QoL with type 2 diabetes patients in relation to method of current anti- diabetic treatment, especially patients who are on the threshold of insulin therapy introduction. Methods: study involved 274 patients [mean 62.2years, 55.8%F) who were divided into 3 groups: patients treated with oral anti-diabetic agents (OAD group, n=111), patients, for whom insulin was introduced (lntensification group, n=68) and patients treated with insulin [Insulin group, n=95). QoL was measured with questionnaires: EQ-5D, DQL-BCI and DSC-R. Results: There were no statistically significant differences in EQ-5D indices among studied patients [OAD group-0.82, lntensification group-0.78, Insulin group-O.75]. EQ-VAS among patients switched to insulin therapy was lower than in OAD group (52.7 and 59.3, respectively, p=0.004]. The differences in DQL-BCI scores among all groups of patients were statistically insignificant (scores: OAD group-56.7, lntensification group-54.8, Insulin group-51.7). DSC-R score in lntensification group was higher than among OAD group (30.9 and 25.3, respectively, p=0,08). Patients switched to insulin therapy manifested the highest level of hyperglycemia-related burden and the lowest treatment satisfaction. Conclusions: patients whose treatment was intensified reported their QoL as lower than the patients treated with OAD, however there was no significant difference found in respect of QoL between patients from the latter group and patients already treated with insulin.^ajakość życia^aquality of life^ainsulinoterapia^ainsulin therapy ; lving insulin therapy is often delayed because of fear of negative influence on quality of life [QoL]. Aims: evaluation of differences on QoL with type 2 diabetes patients in relation to method of current anti- diabetic treatment, especially patients who are on the threshold of insulin therapy introduction. Methods: study involved 274 patients [mean 62.2years, 55.8%F) who were divided into 3 groups: patients treated with oral anti-diabetic agents (OAD group, n=111), patients, for whom insulin was introduced (lntensification group, n=68) and patients treated with insulin [Insulin group, n=95). QoL was measured with questionnaires: EQ-5D, DQL-BCI and DSC-R. Results: There were no statistically significant differences in EQ-5D indices among studied patients [OAD group-0.82, lntensification group-0.78, Insulin group-O.75]. EQ-VAS among patients switched to insulin therapy was lower than in OAD group (52.7 and 59.3, respectively, p=0.004]. The differences in DQL-BCI scores among all groups of patients were statistically insignificant (scores: OAD group-56.7, lntensification group-54.8, Insulin group-51.7). DSC-R score in lntensification group was higher than among OAD group (30.9 and 25.3, respectively, p=0,08). Patients switched to insulin therapy manifested the highest level of hyperglycemia-related burden and the lowest treatment satisfaction. Conclusions: patients whose treatment was intensified reported their QoL as lower than the patients treated with OAD, however there was no significant difference found in respect of QoL between patients from the latter group and patients already treated with insulin.^ajakość życia^aquality of life^ainsulinoterapia^ainsulin therapy
Słowa kluczowe: ;

Streszczenie:

  Wyświetl ponownie stosując format:
Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka AB